Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FX1XJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $148,788
Award facts
- Contract value 100% obligated
- $148,787.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $148,787.74 by the Defense Logistics Agency (DLA) on June 2, 2025. The delivery order, which is not subject to any set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. The place of performance is Park Ridge, Illinois, with an ultimate completion date of June 3, 2025. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 through November 2026.
The DLA's SPE2DB indefinite delivery contract enables the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items supporting medical supply needs at Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a demonstrated track record of delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities. This particular delivery order for Trikafta, a cystic fibrosis treatment medication, represents one of numerous pharmaceutical product deliveries the contractor provides to support the DLA's healthcare distribution operations.
Quick answers
Who was awarded contract SPE2DB25FX1XJ?
SPE2DB25FX1XJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FX1XJ worth?
The government has obligated $148,788 on SPE2DB25FX1XJ.
Is contract SPE2DB25FX1XJ an order under another contract?
Yes. SPE2DB25FX1XJ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1XJ competed?
The extent of competition for SPE2DB25FX1XJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award